Endocrine Abstracts

Background: With the increasing use of cancer immunotherapies in advanced solid organ and hematologic malignancies, endocrinologists are beckoned to manage endocrine complications with unique presentations and natural history in the already challenged oncology patient. We describe four patients illustrating the multifarious endocrine adversities of checkpoint inhibitors.Cases: Patient 1 is a 35-year old male with refractory Hodgkin’s lymphoma, previ...